Pravastatin sodium and Fenofibrate drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Pravastatin sodium and Fenofibrate together. This study is created by eHealthMe based on reports of 252 people who take Pravastatin sodium and Fenofibrate from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on pravastatin sodium and fenofibrate (the active ingredients of Pravastatin sodium and Fenofibrate, respectively), and Pravastatin sodium and Fenofibrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Pravastatin sodium?

Pravastatin sodium has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. (latest outcomes from Pravastatin sodium 16,024 users)

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. (latest outcomes from Fenofibrate 22,226 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 04, 2019

252 people who take Pravastatin sodium, Fenofibrate are studied.


Number of reports submitted per year:

Pravastatin sodium and Fenofibrate drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Constipation
  2. Fatigue (feeling of tiredness)
  3. Gait disturbance
  4. Intervertebral disc degeneration (spinal disc degeneration)
  5. Muscle atrophy (a decrease in the mass of the muscle)
  6. Muscle fatigue (a condition in which muscles cannot exert their normal force)
  7. Myalgia (muscle pain)
  8. Oedema mouth (swelling of mouth)
  9. Quality of life decreased
  10. Renal failure chronic (long lasting kidney dysfunction)
6 - 12 months:
  1. Asthenia (weakness)
  2. Blood glucose increased
  3. Cough
  4. Diarrhoea
  5. Disease recurrence
  6. Erysipelas (bacterial skin infection)
  7. Gastric erosions (gradual destruction of surface layer of the membrane lining the stomach)
  8. Haemangioma acquired (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs-acquired)
  9. Hoarseness (changing voice)
  10. Necrosis (the stage of dying)
1 - 2 years:
  1. Chronic kidney disease
  2. Renal injury (kidney injury)
  3. Restless legs syndrome (a powerful urge to move your legs)
  4. Tendon disorder (disease of tendon)
2 - 5 years:
  1. Fatigue (feeling of tiredness)
  2. Gait disturbance
  3. Intervertebral disc degeneration (spinal disc degeneration)
  4. Muscle atrophy (a decrease in the mass of the muscle)
  5. Muscle fatigue (a condition in which muscles cannot exert their normal force)
  6. Myalgia (muscle pain)
  7. Oedema mouth (swelling of mouth)
  8. Quality of life decreased
  9. Renal failure chronic (long lasting kidney dysfunction)
  10. Sleep disorder
5 - 10 years:
  1. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  2. Plasma cell myeloma (cancer that begins in plasma cells)
  3. Pre-existing condition improved
  4. Therapeutic response unexpected
  5. Condition
  6. Fall
  7. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  8. Somnambulism (sleep walking)
  9. Urinary incontinence (inability to control the flow of urine and involuntary urination)
10+ years:

n/a

not specified:
  1. Pyrexia (fever)
  2. Blood glucose increased
  3. Decreased appetite
  4. Dyspnoea (difficult or laboured respiration)
  5. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  6. Aspartate aminotransferase increased
  7. Blood potassium decreased
  8. Death
  9. Gait disturbance
  10. Mitral valve incompetence (inefficient heart valve)

Most common drug interactions by gender *:

female:
  1. Rash
  2. Anxiety
  3. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  4. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  5. Weight decreased
  6. Arthralgia (joint pain)
  7. Fall
  8. Dizziness
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Weight increased

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:
  1. Asthma
  2. Dizziness
  3. Headache (pain in head)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Pancreatitis (inflammation of pancreas)
  6. Peak expiratory flow rate decreased
  7. Renal disorder (kidney disease)
  8. Wheezing (a high-pitched whistling sound made while you breath)
20-29:

n/a

30-39:
  1. Hallucination, auditory (perceiving sounds without auditory stimulus)
  2. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  3. Fallot's tetralogy (birth heart defect of 5 chambers)
  4. Maternal exposure during pregnancy (use of substance during pregnancy)
  5. Multiple congenital abnormalities (more than one birth defects)
  6. Pulmonary artery atresia (lungs artery absent)
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  9. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  10. Balance disorder
40-49:
  1. Chronic allograft nephropathy (failure of kidney transplant)
  2. Nephropathy toxic (damage to kidney due to toxins)
  3. Bite
  4. Blood creatine phosphokinase increased
  5. Blood glucose
  6. Carotid artery stenosis (narrowing of carotid artery)
  7. Cellulitis (infection under the skin)
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Depression
  10. Diarrhoea
50-59:
  1. Drug ineffective
  2. Hyperhidrosis (abnormally increased sweating)
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Haematocrit decreased
  5. Haemoglobin decreased
  6. Red blood cell count decreased
  7. Dyspnoea (difficult or laboured respiration)
  8. Weight decreased
  9. Arthralgia (joint pain)
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
60+:
  1. Gait disturbance
  2. Myalgia (muscle pain)
  3. Anxiety
  4. Constipation
  5. Death
  6. Decreased appetite
  7. Headache (pain in head)
  8. Intervertebral disc degeneration (spinal disc degeneration)
  9. Muscle atrophy (a decrease in the mass of the muscle)
  10. Muscle fatigue (a condition in which muscles cannot exert their normal force)

* Approximation only. Some reports may have incomplete information.

Do you take Pravastatin sodium and Fenofibrate?


You are not alone:




Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Pravastatin sodium and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Fenofibrate and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Pravastatin sodium and Fenofibrate
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Pravastatin sodium and Fenofibrate (18,725 reports studied)



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!